An antiseptic composition suitable for use on skin and wounds comprising a source of an antimicrobial agent and an agent which disrupts biofilms. More, particularly the invention relates to a composition capable of providing effective antimicrobial activity while at the same time avoiding wound and skin irritation and retardation of wound healing.

A monomeric adhesive composition includes a stabilized polymerizable monomer, such as a 1,1-disubstituted monomer, including a cyanoacrylate, and a wound healing agent, wherein the wound healing agent is 5,5-disubstitutedhydantoin, including phenytoin; and a method for making said composition.

The present disclosure specifically relates to a liquid dressing for promoting wound healing. The liquid dressing comprises components of, in percentage by weight: 1% to 2% of monomeric silicic acid and 98% to 99% of distilled water. The liquid dressing also comprises aloe, vitamin C, fish oil, and curcumin. The components comprise, in percentage by weight: 1% to 2% of monomeric silicic acid, 3% to 5% of aloe, 5% to 7% of vitamin C, 1% to 3% of fish oil, 1% to 2% of curcumin, and the balance being the distilled water. The liquid dressing for promoting wound healing in the present disclosure has a great promotion effect on wound healing, particularly in accelerating healing of refractory wounds caused by hyperglycemia. Moreover, the liquid dressing for promoting wound healing in the present disclosure has a certain auxiliary effect on other refractory wounds that do not heal for a long time.

A formulation is disclosed for use in wound healing. The formulation may include hypochlorous acid, a silicone polymer or blend thereof, sodium phosphate, hydrochloric acid, and sodium magnesium silicate. Methods of using and making the wound healing formulation are also disclosed.

The present disclosure relates to medicated skin concealers and methods associated therewith.

A biobased wound healing preparation including a nanocomposite including olive leaf extract, beef bone meal, and moringa seed gel, an organic composition including one or more of a beetroot dye, black cumin seed, sodium fusidate, salicylic acid, chicken-sourced glycerin, and pomegranate peel pigment, an adhesive component including one or more of a cyanoacrylate, Acacia nilotica glue, coconut gel, okra gel, aloe vera gel, and aroid root gum, and ZnO nanoparticles. The nanocomposite is in the form of nanoparticles having an average particle size of 25 nm or less.

The invention relates to hemostatic compositions comprising ellagic acid-metal complex and uses thereof for activating the intrinsic pathway of blood coagulation. In particular, disclosed are hemostatic compositions comprised of ellagic acid complexed with nickel ions, the complex being dispersed or embedded within an absorbable polymeric matrix such as gelatin. Further disclosed are method for making the hemostatic compositions.

The present disclosure relates to the technical field of hemostatic materials, and particularly relates to a kaolin-based hemostatic material with an anti-inflammatory function and a preparation method and use thereof. The kaolin-based hemostatic material with the anti-inflammatory function in the present disclosure includes CeO.sub.2 nanoparticle-loaded kaolin. The preparation method includes: mixing kaolin, cerium chloride, sodium carbonate, and sodium chloride in a mass ratio, and ball-milling to produce a precursor; and roasting the precursor to produce the kaolin-based hemostatic material with the anti-inflammatory function. In the present disclosure, with low-cost and abundantly-available kaolinite and the conventional CeO.sub.2 as raw materials, a CeO.sub.2-loaded kaolin-based nanomaterial is prepared through mechanochemical synthesis. The prepared CeO.sub.2/K nanomaterial has synergistic anti-inflammatory and hemostatic activities.

Novel compositions and systems for closure of wounds with antimicrobial effectiveness are disclosed. The compositions provide devices of improved flexibility and elasticity and are readily applied to wound sites or over wound closure devices. The present invention is also directed to a novel platinum catalyst for use in such compositions. The catalyst provides for rapid curing on topical surfaces such as skin and bonds to such surfaces in about 2-5 minutes.

The present disclosure relates to wound dressings and amorphous gel dressings for treating a wound, skin lesion, or burn. The wound dressing or amorphous gel dressing of the present disclosure having one or more nitrite salts, at least one acid and a conjugate base to form a buffer system, among other things.